Reg Waldeck MSc, PhD

Reg Waldeck is the head of Market Access, Pricing, Health Economics and Payer Communications at Celldex Therapeutics Inc., a biotechnology company developing targeted therapeutics for patients with devastating diseases, with a current portfolio focused within immuno-oncology. He directs departmental efforts in support of successful access, evidence-generation, and commercialization of the Celldex portfolio.

Dr. Waldeck received an MSc (Chemistry) from the University of Amsterdam, a PhD (Biochemistry) from the University of Sydney, and has completed post-graduate certificates in Health Economics (Monash University, Australia) and Marketing (University of Connecticut, USA).